Last updated: 2026-10-14 13:42:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Alcon Inc. (ALC) operates in the -- sector and is listed on NYSE. The stock is currently priced at $63.89, with a market capitalisation of $31.11B and a P/E ratio of 69.21. Over the past 52 weeks, its price has ranged from $61.84 to $87.64. This page covers its latest market performance, valuation, price trends and company information.
$31.11B | |
$63.20 | |
$101.10 | |
$2.50 | |
$63.00 | |
112.58K | |
1.81M | |
69.21 | |
$87.64 | |
$61.84 | |
-- | |
-- |
Alcon Inc. (ALC) is currently trading at $63.89 as of 2026-10-14 13:41:00, up 1.42% ($0.89) from the previous close of $63.00
During today's regular trading session, ALC has traded between $2.50 and $101.10, with a trading volume of 112.58K shares. The current price is near the middle of today's range.
Over the past seven days, Alcon Inc. (ALC) moved from $64.33 to $63.89, representing a decline of 0.68% ($0.44).
The stock traded between $62.10 and $64.52 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 1.74 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 8.0%
ALC is currently trading at $63.89, placing it 8.0% of the way from its 52-week low of $61.84 to its 52-week high of $87.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
| Employees | 25942 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Alcon Inc. (ALC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.